Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) NSE

Currency In INR

AD

Valuation

Market Cap420.17M
Enterprise Value417.11M
P/E Ratio102.33
PEG Ratio-1.24
Price/Sales Ratio1.44
Price/Book Ratio2.28
Enterprise/Revenue1.43
Enterprise/EBITDA51.17

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue283.95M
Revenue/Share21.08
Gross Profit10.37M
EBITDA37.32M
Net Income27.86M
Diluted EPS1.71

Balance Sheet

Total Cash33.26M
Total Cash/Share2.04
Total Debt30.2M
Total Debt/Equity0.14
Current Ratio1.73
Book Value Per Share13.25

Price History

52-Week Change-31.62
52-Week High46.34
52-Week Low25.6
Moving Average 50 Days33.61
Moving Average 200 Days33.56

Statistics

Average Volume55,794
Shares Outstanding16.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD